Elizabeth Swann
- Co-authors
- Christopher J. MoodyDavid RossDavid SiegelShannon L. WinskiHoward D. BeallDonna L. DehnAnna R. HudnottPaola Barraja
- Topics
- Bioactive Compounds and Antitumor Agents (20 papers)Cancer therapeutics and mechanisms (8 papers)Genomics, phytochemicals, and oxidative stress (6 papers)
- Partner nations
- United KingdomUnited StatesPortugal
In The Last Decade
Elizabeth Swann
34 papers receiving 990 citations
Peers
Comparison fields: 5 of 69
- Organic Chemistry 626
- Molecular Biology 530
- Toxicology 403
- Cancer Research 69
- Inorganic Chemistry 56
Countries citing papers authored by Elizabeth Swann
This map shows the geographic impact of Elizabeth Swann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth Swann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth Swann more than expected).
Fields of papers citing papers by Elizabeth Swann
This network shows the impact of papers produced by Elizabeth Swann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth Swann. The network helps show where Elizabeth Swann may publish in the future.
Co-authorship network of co-authors of Elizabeth Swann
This figure shows the co-authorship network connecting the top 25 collaborators of Elizabeth Swann. A scholar is included among the top collaborators of Elizabeth Swann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elizabeth Swann. Elizabeth Swann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 6 | |
| 2 | 18 | |
| 3 | 17 | |
| 4 | 34 | |
| 5 | 45 | |
| 6 | 47 | |
| 7 | 26 | |
| 8 | 23 | |
| 9 | 46 | |
| 10 | 35 | |
| 11 | 3 | |
| 12 | 23 | |
| 13 | 34 | |
| 14 | 16 | |
| 15 | 1 | |
| 16 | Novel bioreductive anticancer agents based on indolequinones. | 11 |
| 17 | 21 | |
| 18 | 36 | |
| 19 | 15 | |
| 20 | 25 |
About Elizabeth Swann
Elizabeth Swann is a scholar working on Toxicology, Organic Chemistry and Cancer Research, having authored 34 papers that have together received 1.0k indexed citations. Recurring topics across this work include Bioactive Compounds and Antitumor Agents (20 papers), Cancer therapeutics and mechanisms (8 papers) and Genomics, phytochemicals, and oxidative stress (6 papers). The work is most often cited by research in Toxicology (403 citations), Organic Chemistry (626 citations) and Molecular Biology (530 citations). Elizabeth Swann has collaborated with scholars based in United Kingdom, United States and Portugal. Frequent co-authors include Christopher J. Moody, David Ross, David Siegel, Shannon L. Winski, Howard D. Beall, Donna L. Dehn, Anna R. Hudnott, Paola Barraja, Ned A. Porter and Ian J. Stratford. Their work appears in journals such as Journal of the American Chemical Society, Biochemistry and Chemical Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.